A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome

NCT05856526 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Netherton Syndrome

Interventions

DRUG: Spesolimab - solution for infusion
DRUG: Placebo matching to spesolimab - solution for infusion
DRUG: Spesolimab - solution for injection
DRUG: Placebo matching to spesolimab - solution for injection

Sponsor

Boehringer Ingelheim